https://scholars.lib.ntu.edu.tw/handle/123456789/641683
標題: | Low- or standard-dose edoxaban versus antiplatelet therapy for leaflet thrombus and cerebral thromboembolism after TAVR: A prespecified analysis of randomized ADAPT-TAVR trial | 作者: | Kim, Mijin Ahn, Jung-Min Kang, Do-Yoon Kim, Min-Ju Kim, Kyung Won Koo, Hyun Jung Yang, Dong Hyun Jung, Seung Chai Kim, Byungjun Wong, Yiu Tung Anthony Lam, Cheung Chi Simon Yin, Wei-Hsian Wei Jeng Lee, Yung-Tsai Kao, Hsien-Li MAO-SHIN LIN Yu Ko, Tsung Kim, Won-Jang Kang, Se Hun Lee, Seung-Ah Ko, Euihong Kim, Dae-Hee Kang, Joon-Won Lee, Jae-Hong Lee, Jinho Park, Jinsun Kim, Hoyun Choi, Yeonwoo Park, Seung-Jung Park, Duk-Woo |
公開日期: | 三月-2024 | 卷: | 269 | 起(迄)頁: | 167 | 來源出版物: | American heart journal | 摘要: | The risks of leaflet thrombosis and the associated cerebral thromboembolism are unknown according to different anticoagulation dosing after transcatheter aortic valve replacement (TAVR). The aim was to evaluate the incidence of leaflet thrombosis and cerebral thromboembolism between low-dose (30 mg) or standard-dose (60 mg) edoxaban and dual antiplatelet therapy (DAPT) after TAVR. |
URI: | https://pubmed.ncbi.nlm.nih.gov/38123045/ https://scholars.lib.ntu.edu.tw/handle/123456789/641683 |
ISSN: | 00028703 | DOI: | 10.1016/j.ahj.2023.12.006 |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。